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Aims and objectives
Proton magnetic resonance spectroscopy ( 1 H-MRS) has been proposed as a tool to assess male infertility providing metabolic signatures related to the spermatogenesis in the testis. This study sought to identify the role of 1 H-MRS in the diagnosis of infertility in patients with semen analysis altered.
Methods and materials
Subjects
14 patients (27 testicles) with fertility problems and with an altered semen analysis (5 oligospermia, 3 astenospermia, 6 oligoastenospermia) and 9 controls (18 testicles) with normal spermatogenesis assessed (men with prior paternity and normal semen analysis ) and normal testicles at magnetic resonance (MR) and ultrasonography (US) with colour Doppler (CD) examination were included.
The exclusion criteria for this study were the inability to perform MRI.
Image technique
All patients underwent CDUS performed by experienced operators who used a highresolution transducer (7-17 MHz linear-array probe) with B-flow (B-mode flow), colour Doppler and power Doppler (GE Healthcare Logic 7, Philips iU22). Automatic settings for testicular examination were used, and the operator modified the pulse repetition frequency (PRF), focal zone, gain and wall filter to obtain optimal colour Doppler flow.
Those patients underwent also conventional MR examination at 1.5T including fast spinecho (FSE) sequences, T1 and T2 weighted images in three orthogonal planes.
A Philips Achieva 1.5 Tesla system was used with a 14 cm circular surface coil, 10×12-cm field of view, 256×256 matrix and 3 mm slice thickness.
Proton magnetic resonance spectroscopy ( 1 H-MRS) was also performed: Single-voxel PRESS (TR 2000 ms/TE 31 ms) with 128 averages) under during free-breathing pattern. Three chemical-shift-selective radiofrequency wave pulses, each followed by dephasing gradient pulses, suppressed the water peak. Volume of interest (15 × 15 ×15 mm) placed in the testis parenchyma avoiding contamination from adjacent structures (Figure 1 ).
3.Statistical analysis
Statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) version 20.0, IBM Corp, Armonk, NY, USA .
Mann Whitney test was used to compare major metabolites peaks (choline, creatine, lipids, lactate) between the patients and controls.
